Suppr超能文献

特发性肺纤维化的诊断程序管理。

Managing diagnostic procedures in idiopathic pulmonary fibrosis.

机构信息

Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.

出版信息

Eur Respir Rev. 2013 Jun 1;22(128):158-62. doi: 10.1183/09059180.00001213.

Abstract

Idiopathic pulmonary fibrosis (IPF), the most prevalent of the idiopathic interstitial pneumonias, is associated with a poor prognosis. An accurate diagnosis of IPF is essential for its optimal management. The 2011 American Thoracic Society (ATS)/European Respiratory Society (ERS)/Japanese Respiratory Society (JRS)/Latin American Thoracic Association (ALAT) recommendations on the diagnosis and management of IPF were developed from a systematic review of the published literature. High-resolution computed tomography (HRCT) scanning has a central role in the IPF diagnostic pathway, with formal designation of criteria for an HRCT pattern of usual interstitial pneumonia. In the correct clinical context, a usual interstitial pneumonia pattern on HRCT is indicative of a definite diagnosis of IPF and negates the need for a surgical lung biopsy. However, although the 2011 ATS/ERS/JRS/ALAT statement is a major advance, the application of the guideline recommendations by clinicians has identified limitations that should be addressed in future statements. Key problems include: 1) HRCT misdiagnosis, particularly by less experienced radiologists; 2) lack of management recommendations for the highly prevalent clinical scenarios of "probable" or "possible" IPF; 3) ongoing confusion concerning the diagnostic role of bronchoalveolar lavage; and 4) the lack of integration of clinical data in the designation of the diagnostic likelihood of IPF, including the treated course of disease. These issues become evident as the recommendations are applied and highlight the need for continued guideline adjustments.

摘要

特发性肺纤维化(IPF)是特发性间质性肺炎中最常见的一种,预后较差。准确诊断 IPF 对其最佳管理至关重要。2011 年美国胸科学会(ATS)/欧洲呼吸学会(ERS)/日本呼吸学会(JRS)/拉丁美洲胸科学会(ALAT)关于 IPF 的诊断和管理的建议是基于对已发表文献的系统评价制定的。高分辨率计算机断层扫描(HRCT)扫描在 IPF 诊断途径中具有核心作用,正式指定了常见间质性肺炎的 HRCT 模式标准。在正确的临床背景下,HRCT 上的常见间质性肺炎模式提示明确的 IPF 诊断,无需进行外科肺活检。然而,尽管 2011 年 ATS/ERS/JRS/ALAT 声明是一项重大进展,但临床医生对指南建议的应用已经确定了一些限制,这些限制应在未来的声明中得到解决。关键问题包括:1)HRCT 误诊,特别是经验较少的放射科医生;2)缺乏“可能”或“很可能”IPF 等高度普遍临床情况下的管理建议;3)关于支气管肺泡灌洗诊断作用的持续混淆;4)在指定 IPF 的诊断可能性时缺乏临床数据的整合,包括疾病的治疗过程。随着建议的应用,这些问题变得明显,突出了需要不断调整指南。

相似文献

1
Managing diagnostic procedures in idiopathic pulmonary fibrosis.
Eur Respir Rev. 2013 Jun 1;22(128):158-62. doi: 10.1183/09059180.00001213.
2
The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)--practical implications.
Respir Res. 2013;14 Suppl 1(Suppl 1):S2. doi: 10.1186/1465-9921-14-S1-S2. Epub 2013 Apr 16.
3
Home treatment for mental health problems: a systematic review.
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
Diagnostic and prognostic trajectories of interstitial lung diseases after the multidisciplinary discussion.
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251323487. doi: 10.1177/17534666251323487. Epub 2025 Mar 13.
7
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Cochrane Database Syst Rev. 2016 Jan 21(1):CD009530. doi: 10.1002/14651858.CD009530.pub3.
8
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Cochrane Database Syst Rev. 2018 Sep 17;9(9):CD009530. doi: 10.1002/14651858.CD009530.pub4.

引用本文的文献

1
Speaking of the "Devil": Diagnostic Errors in Interstitial Lung Diseases.
J Pers Med. 2023 Nov 10;13(11):1589. doi: 10.3390/jpm13111589.
2
Global incidence and prevalence of idiopathic pulmonary fibrosis.
Respir Res. 2021 Jul 7;22(1):197. doi: 10.1186/s12931-021-01791-z.
4
Computer-Aided Diagnosis of Pulmonary Fibrosis Using Deep Learning and CT Images.
Invest Radiol. 2019 Oct;54(10):627-632. doi: 10.1097/RLI.0000000000000574.
5
Risk factors for diagnostic delay in idiopathic pulmonary fibrosis.
Respir Res. 2019 May 24;20(1):103. doi: 10.1186/s12931-019-1076-0.
7
Triple kinase inhibitor with phosphodiesterase-5 inhibitor for idiopathic pulmonary fibrosis.
J Thorac Dis. 2018 Nov;10(11):5974-5978. doi: 10.21037/jtd.2018.10.84.
10
Idiopathic pulmonary fibrosis: A guide for nurse practitioners.
Nurse Pract. 2018 May 17;43(5):48-54. doi: 10.1097/01.NPR.0000531121.07294.36.

本文引用的文献

1
An earlier and more confident diagnosis of idiopathic pulmonary fibrosis.
Eur Respir Rev. 2012 Jun 1;21(124):141-6. doi: 10.1183/09059180.00000812.
2
The rising incidence of idiopathic pulmonary fibrosis in the U.K.
Thorax. 2011 Jun;66(6):462-7. doi: 10.1136/thx.2010.148031. Epub 2011 Apr 27.
3
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
4
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2010 Apr 15;181(8):832-7. doi: 10.1164/rccm.200906-0959OC. Epub 2010 Jan 7.
5
Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2009 Jun 1;179(11):1043-7. doi: 10.1164/rccm.200808-1313OC. Epub 2009 Feb 26.
7
Idiopathic pulmonary fibrosis.
Orphanet J Rare Dis. 2008 Mar 26;3:8. doi: 10.1186/1750-1172-3-8.
8
Advanced chronic lung disease: need for an active interdisciplinary approach.
Swiss Med Wkly. 2007 Nov 3;137(43-44):593-601. doi: 10.4414/smw.2007.11680.
9
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?
Am J Respir Crit Care Med. 2007 May 15;175(10):1054-60. doi: 10.1164/rccm.200606-833OC. Epub 2007 Jan 25.
10
Incidence and prevalence of idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2006 Oct 1;174(7):810-6. doi: 10.1164/rccm.200602-163OC. Epub 2006 Jun 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验